Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen
- PMID: 7515448
- DOI: 10.1016/s0022-5347(17)32834-3
Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen
Abstract
We reviewed the surgical specimen from 142 men undergoing radical prostatectomy for prostate cancer detected because of an elevation in serum prostate specific antigen alone. No patient had a palpable abnormality suggestive of cancer. One patient had no identifiable tumor in the radical prostatectomy specimen, 8 (6%) had only a few high power microscopic fields showing cancer, 40 (28%) had an estimated tumor volume of less than 1 cc and 93 (65%) had a tumor volume of greater than 1 cc. Surgical margins were positive in 37 patients (26%) and negative in 105 (73%). Most patients with cancer detected because of modest elevation in prostate specific antigen, even without palpable abnormalities, have a clinically significant tumor volume and are good candidates for radical prostatectomy.
Comment in
-
Prostate cancer: if we only had more data.J Urol. 1994 Jul;152(1):135. doi: 10.1016/s0022-5347(17)32836-7. J Urol. 1994. PMID: 7515449 No abstract available.
Similar articles
-
Minute focus of prostate cancer on needle biopsy: correlation with radical prostatectomy specimen.Arch Ital Urol Androl. 2009 Mar;81(1):9-12. Arch Ital Urol Androl. 2009. PMID: 19499751
-
Correlation of minute (0.5 MM or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: role of prostate specific antigen density.J Urol. 2003 Aug;170(2 Pt 1):370-2. doi: 10.1097/01.ju.0000074747.72993.cb. J Urol. 2003. PMID: 12853777
-
Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.J Urol. 2001 Jul;166(1):104-9; discussion 109-10. J Urol. 2001. PMID: 11435833
-
Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).J Urol. 1994 Nov;152(5 Pt 2):1721-9. doi: 10.1016/s0022-5347(17)32370-4. J Urol. 1994. PMID: 7523719 Review.
-
The role of the reverse-transcriptase polymerase chain reaction assay for prostate-specific antigen in the selection of patients for radical prostatectomy.Urol Clin North Am. 1996 Nov;23(4):541-9. doi: 10.1016/s0094-0143(05)70334-7. Urol Clin North Am. 1996. PMID: 8948409 Review.
Cited by
-
Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer.World J Urol. 1997;15(6):339-45. doi: 10.1007/BF01300181. World J Urol. 1997. PMID: 9436283 Clinical Trial.
-
Expectant management as an option for men with stage T1c prostate cancer: a preliminary study.World J Urol. 1997;15(6):364-8. doi: 10.1007/BF01300184. World J Urol. 1997. PMID: 9436286
-
Evaluating radical prostatectomy specimens: therapeutic and prognostic importance.Virchows Arch. 1997 Jan;430(1):1-16. doi: 10.1007/BF01008010. Virchows Arch. 1997. PMID: 9037309 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical